Clinical trials
Completed Muscle Spasticity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
356 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 5 |
| 2002 | 9 |
| 2003 | 7 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 11 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 8 |
| 2011 | 12 |
| 2012 | 16 |
| 2013 | 18 |
| 2014 | 19 |
| 2015 | 16 |
| 2016 | 17 |
| 2017 | 15 |
| 2018 | 24 |
| 2019 | 23 |
| 2020 | 18 |
| 2021 | 29 |
| 2022 | 25 |
| 2023 | 19 |
| 2024 | 19 |
| 2025 | 14 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 356 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allergan | 14 |
| Ipsen | 14 |
| Riphah International University | 11 |
| Chang Gung Memorial Hospital | 9 |
| Jazz Pharmaceuticals | 8 |
| GlaxoSmithKline | 6 |
| Medy-Tox | 6 |
| Vanderbilt University | 6 |
| Cairo University | 5 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscle Spasticity | 356 |
| Stroke | 128 |
| Cerebral Palsy | 86 |
| Multiple Sclerosis | 37 |
| Hemiplegia | 31 |
| Spinal Cord Injuries | 30 |
| Pain | 13 |
| Paresis | 12 |
| Muscle Hypertonia | 10 |
| Motor Neuron Disease | 7 |
Trials
Showing 1 to 25 of 356. Each trial links to its page on Pharma Observatory.
256 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.